At a glance
- Originator Bristol-Myers Squibb
- Class Antifungals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Candidiasis
Most Recent Events
- 29 Nov 1995 Discontinued-I for Candidiasis in USA (PO)
- 20 Jan 1995 No-Development-Reported for Candidiasis in USA (PO)